TrialCirculation2023

Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.

Moritz J Hundertmark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.